The field is evolving. We are moving away from "one size fits all" medicine toward Precision Medicine.
By studying Pharmacogenomics—how a person's genetic makeup affects their response to drugs—pharmacologists can now predict who will benefit from a drug and who might suffer toxic side effects. pharmacology in drug discovery and development
Before a single compound is synthesized, pharmacology asks the most critical question: Is this target druggable? The field is evolving
Modern pharmacology has moved beyond simple "on/off" switches. Today's discovery pipelines focus on nuance: pharmacology in drug discovery and development
Case in point: Beta-blockers (like propranolol) are antagonists at beta-adrenergic receptors. Their PD profile—specifically, their ability to block adrenaline without activating the receptor—lowers heart rate and blood pressure. A molecule with slightly different PD properties (partial agonism) would fail as a beta-blocker.